Figure 3
From: A glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effects
In vitro cytotoxicity and ROS assay.
(a) CA or CA + Glc treatment resulted in approximately 90% cell viability in HCT116 or HT29 cells at the indicated times. CA-[Glc] containing the same concentration of Glc or CA significantly reduced the growth of HCT116 cells to 60% viability at 48 h, or HT29 cells to 40 ~ 50%, at 48 and 72 h post-treatment (n = 6, Steel-Dwass All Pairs Test). (b) The cell morphology of CA, CA + Glc, or CA-[Glc] treated HCT116 and HT29 cells at 48 h. (c) The relative ROS intensity in the HCT116 or HT29 cells treated with CA-[Glc] showed significantly higher than those with CA or CA + Glc (n = 5 ~ 10, Steel-Dwass All Pairs Test).
